Ma W - Search Results

1

Targeted next-generation sequencing of circulating cell-free DNA vs bone marrow in patients with acute myeloid leukemia.

Short NJ, Patel KP, Albitar M, Franquiz M, Luthra R, Kanagal-Shamanna R, Wang F, Assi R, Montalban-Bravo G, Matthews J, Ma W, Loghavi S, Takahashi K, Issa GC, Kornblau SM, Jabbour E, Garcia-Manero G, Kantarjian HM, Estrov Z, Ravandi F. Short NJ, et al. Among authors: ma w. Blood Adv. 2020 Apr 28;4(8):1670-1677. doi: 10.1182/bloodadvances.2019001156. Blood Adv. 2020. PMID: 32324887 Free PMC article.

2

Plasma RNA as an alternative to cells for monitoring molecular response in patients with chronic myeloid leukemia.

Ma W, Tseng R, Gorre M, Jilani I, Keating M, Kantarjian H, Cortes J, O'Brien S, Giles F, Albitar M. Ma W, et al. Haematologica. 2007 Feb;92(2):170-5. doi: 10.3324/haematol.10360. Haematologica. 2007. PMID: 17296565 Free article.

3

Enzymatic activity of circulating proteasomes correlates with clinical behavior in patients with chronic lymphocytic leukemia.

Ma W, Kantarjian H, O'Brien S, Jilani I, Zhang X, Estrov Z, Ferrajoli A, Keating M, Giles F, Albitar M. Ma W, et al. Cancer. 2008 Mar 15;112(6):1306-12. doi: 10.1002/cncr.23301. Cancer. 2008. PMID: 18224667 Free article.

4

Higher detection rate of JAK2 mutation using plasma.

Ma W, Kantarjian H, Zhang X, Sun W, Buller AM, Jilani I, Schwartz JG, Giles F, Albitar M. Ma W, et al. Blood. 2008 Apr 1;111(7):3906-7. doi: 10.1182/blood-2008-02-139188. Blood. 2008. PMID: 18362222 Free article. No abstract available.

5

BCR-ABL alternative splicing as a common mechanism for imatinib resistance: evidence from molecular dynamics simulations.

Lee TS, Ma W, Zhang X, Giles F, Cortes J, Kantarjian H, Albitar M. Lee TS, et al. Among authors: ma w. Mol Cancer Ther. 2008 Dec;7(12):3834-41. doi: 10.1158/1535-7163.MCT-08-0482. Epub 2008 Dec 3. Mol Cancer Ther. 2008. PMID: 19056677

6

Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias.

Ma W, Kantarjian H, Zhang X, Yeh CH, Zhang ZJ, Verstovsek S, Albitar M. Ma W, et al. J Mol Diagn. 2009 Jan;11(1):49-53. doi: 10.2353/jmoldx.2009.080114. Epub 2008 Dec 12. J Mol Diagn. 2009. PMID: 19074595 Free PMC article.

7

B-cell clones as early markers for chronic lymphocytic leukemia.

Landgren O, Albitar M, Ma W, Abbasi F, Hayes RB, Ghia P, Marti GE, Caporaso NE. Landgren O, et al. Among authors: ma w. N Engl J Med. 2009 Feb 12;360(7):659-67. doi: 10.1056/NEJMoa0806122. N Engl J Med. 2009. PMID: 19213679 Free PMC article.

8

K-ras mutations and cetuximab in colorectal cancer.

Albitar M, Yeh C, Ma W. Albitar M, et al. Among authors: ma w. N Engl J Med. 2009 Feb 19;360(8):834; author reply 835-6. N Engl J Med. 2009. PMID: 19238675 No abstract available.

9

Detection of nucleophosmin gene mutations in plasma from patients with acute myeloid leukemia: clinical significance and implications.

Ma W, Kantarjian H, Zhang X, Jilani I, Sheikholeslami MR, Donahue AC, Ravandi F, Estey E, O'Brien S, Keating M, Giles FJ, Albitar M. Ma W, et al. Cancer Biomark. 2009;5(1):51-8. doi: 10.3233/CBM-2009-0583. Cancer Biomark. 2009. PMID: 19242062 Clinical Trial.

10

BCR-ABL truncation due to premature translation termination as a mechanism of resistance to kinase inhibitors.

Ma W, Kantarjian H, Yeh CH, Zhang ZJ, Cortes J, Albitar M. Ma W, et al. Acta Haematol. 2009;121(1):27-31. doi: 10.1159/000210060. Epub 2009 Mar 31. Acta Haematol. 2009. PMID: 19332983 Free PMC article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,703 results

Search Page

Filters